Tag Archives: CVC Strategic Opportunities II

CVC Strategic Opportunities Sells Entire Stake in Genetic S.p.A., Strengthening the Company’s Global Position

(IN BRIEF) CVC Strategic Opportunities II has successfully exited its investment in Genetic S.p.A., a pharmaceutical CDMO specializing in Respiratory, Ophthalmic, and Oncology therapeutic products. The exit sees NB Renaissance and NB Aurora joining the Pavese family as shareholders. Under … Read the full press release